Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06073834

LUNG INFECTION in ICU (LUNG-I3)

LUNG INFECTION in ICU

Status
Recruiting
Phase
Study type
Observational
Enrollment
68 (estimated)
Sponsor
BioMérieux · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils

Conditions

Timeline

Start date
2023-12-05
Primary completion
2026-04-01
Completion
2027-06-01
First posted
2023-10-10
Last updated
2025-02-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06073834. Inclusion in this directory is not an endorsement.

LUNG INFECTION in ICU (LUNG-I3) (NCT06073834) · Clinical Trials Directory